Skip to main content
Wellcome Collection homepage
Visit us
What’s on
Stories
Collections
Get involved
About us
Sign in to your library account
Search our stories, images, catalogue and events
Library account
Search our stories, images, catalogue and events
Search
Search the catalogue
Search
The Kennedy Trust for Rheumatology Research
…
Drug Development SA/KET/A
Patents SA/KET/A/4
Category C Owned by The Kennedy Institute Tied to Licensing Agreement With Centocor SA/KET/A/4/3
C3 Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Disease SA/KET/A/4/3/4
C3 Part 3 SA/KET/A/4/3/4/3
C3 Part 3
Date:
2000-2001
Reference:
SA/KET/A/4/3/4/3
Part of:
The Kennedy Trust for Rheumatology Research
Archives and manuscripts
Collection contents
The Kennedy Trust for Rheumatology Research
SA/KET
Drug Development
SA/KET/A
Patents
SA/KET/A/4
Category C Owned by The Kennedy Institute Tied to Licensing Agreement With Centocor
SA/KET/A/4/3
C3 Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Disease
SA/KET/A/4/3/4
C3 Part 3
SA/KET/A/4/3/4/3
About this work
Description
See reference SA/KET/A/4/3/4 for C3 patent description.
Publication/Creation
2000-2001
Physical description
1 file (in 3 parts)
Terms of use
This item is held in offsite storage and requires a longer time for delivery.
Languages
English
French
Where to find it
Location
Status
Access
Closed stores
Permanent link
Page URL